ImmuCell (ICCC) SEC Filings: History & Chart

ImmuCell Corporation(ICCC)

Biotechnology · Portland, ME

$9.97+0.22 (+2.26%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About ImmuCell Corporation

ImmuCell Corporation functions as an animal health enterprise, specializing in the creation, manufacturing, and commercialization of offerings aimed at improving the vitality and output of dairy and beef cattle, serving both the U.S. domestic market and international regions. Among its key products is First Defense, an orally administered preventative designed to combat scours in newborn dairy and beef calves. The company also provides Tri-Shield First Defense, a passive antibody treatment effective against E. coli, coronavirus, and rotavirus. Additionally, ImmuCell offers the California Mastitis Test, a diagnostic instrument used to quantify somatic cell counts in milk and identify which specific udder quarter may be affected by mastitis. Its Dual-Force First Defense product, incorporating a whey protein concentrate, caters to the nutritional and animal feed supplement industries. Currently under development is Re-Tain, a Nisin-based intramammary therapy targeting subclinical mastitis in lactating dairy cows. The company primarily distributes its products through a network of animal health distributors. ImmuCell Corporation was established in 1982 and is based in Portland, Maine.

Portland, ME

73 employees

immucell.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: F. Olivier Te Boekhorst

View full financials

Form	Filing Date	Accepted	Document
10-Q	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Aug 13, 2026	Aug 13, 2026	View filing
8-K	Jul 9, 2026	Jul 9, 2026	View filing
4	Jun 22, 2026	Jun 22, 2026	View filing
8-K	Jun 17, 2026	Jun 17, 2026	View filing
8-K	Jun 10, 2026	Jun 10, 2026	View filing
8-K	May 14, 2026	May 14, 2026	View filing
10-Q	May 14, 2026	May 14, 2026	View filing
10-K/A	May 13, 2026	May 13, 2026	View filing
8-K	May 8, 2026	May 8, 2026	View filing
DEF 14A	Apr 24, 2026	Apr 24, 2026	View filing
3	Apr 23, 2026	Apr 23, 2026	View filing
3	Apr 23, 2026	Apr 23, 2026	View filing
4	Apr 16, 2026	Apr 16, 2026	View filing
4	Apr 16, 2026	Apr 16, 2026	View filing
4	Apr 16, 2026	Apr 16, 2026	View filing
4	Apr 16, 2026	Apr 16, 2026	View filing
PRE 14A	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
4	Apr 14, 2026	Apr 14, 2026	View filing
8-K	Apr 14, 2026	Apr 13, 2026	View filing
8-K	Apr 8, 2026	Apr 8, 2026	View filing
3	Apr 1, 2026	Apr 1, 2026	View filing
10-K	Mar 30, 2026	Mar 30, 2026	View filing
4	Mar 24, 2026	Mar 24, 2026	View filing
4/A	Mar 23, 2026	Mar 23, 2026	View filing

SEC Filings

Recent Filings